HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
6 hedge funds and large institutions have $4.51M invested in Hepion Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+3
Holders Change %
+100%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$1.39M |
| 2 |
Morgan Stanley
New York
|
+$172K |
| 3 |
Barclays
London,
United Kingdom
|
+$170K |
Top Sellers
| 1 |
JPMorgan Chase & Co
New York
|
-$354K |
| 2 |
PFS
Prospera Financial Services
Dallas,
Texas
|
-$287K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$267K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$202K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$142K |
